An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder ...

Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease (EDED ... of hyperkeratinization suggesting that gland atrophy may be a major cause of EDED.

Four months after Europe's Committee for Medicinal Products for Human Use (CHMP) rejected Apellis’ GA application for Syfovre for a second time, Astellas has withdrawn its application for the approval ...

In late-session trading, investors were selling out of Apellis, to the point where its price was down by nearly 6%. By ...

In an interview with Ophthalmology Times, Quan Dong Nugyen, MD, MSc, discusses ongoing research into Tinlarebant, an ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

CHICAGO -- An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and ...

Objective: Multiple system atrophy (MSA) is commonly associated with rapid eye movement sleep behavior disorder (RBD). Research on the prevalence of RBD in MSA and its effects on MSA patients has ...